Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
24 Aug 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
16 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with no updates
|
|
|
31 May 2024 |
CS01 |
Confirmation statement made on 24 May 2024 with no updates
|
|
|
31 May 2024 |
PSC05 |
Change of details for Haleon Uk Enterprises Limited as a person with significant control on 31 May 2024
|
|
|
03 Nov 2023 |
PSC05 |
Change of details for Haleon Uk Enterprises Limited as a person with significant control on 18 July 2022
|
|
|
15 Aug 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
05 Jun 2023 |
PSC05 |
Change of details for Haleon Uk Enterprises Limited as a person with significant control on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH04 |
Secretary's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
25 May 2023 |
CS01 |
Confirmation statement made on 24 May 2023 with updates
|
|
|
19 May 2023 |
CH04 |
Secretary's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
19 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
19 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
14 Apr 2023 |
CERTNM |
Company name changed glaxosmithkline consumer healthcare finance LIMITED\certificate issued on 14/04/23
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2023-04-06
|
|
|
17 Nov 2022 |
CH01 |
Director's details changed for Mr Michael John Rowe on 18 July 2022
|
|
|
03 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
26 Aug 2022 |
PSC05 |
Change of details for Prism Pch Limited as a person with significant control on 22 July 2022
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
24 May 2022 |
CS01 |
Confirmation statement made on 24 May 2022 with no updates
|
|
|
08 Apr 2022 |
SH19 |
Statement of capital on 8 April 2022
|
|
|
08 Apr 2022 |
SH20 |
Statement by Directors
|
|
|
08 Apr 2022 |
CAP-SS |
Solvency Statement dated 05/04/22
|
|
|
08 Apr 2022 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Cancel share prem a/c 05/04/2022
|
|
|
06 Apr 2022 |
TM02 |
Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a secretary on 1 April 2022
|
|